MTVA MetaVia Inc. - Common Stock
$1.49
Price · Aug 19, 2026
Fundamentals as of Aug 6, 2026
52W Range
$1–$13
7% of range
Analyst Rating
BUY
8 analysts
Price Target
$19
+1198% upside
P/E (TTM)
-0.2
ROE
-173.5%
Net Profit Margin
-2543.7%
MTVA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.49
Market Cap
$3M
P/E (TTM)
-0.2
EPS (TTM)
$-7.35
Revenue (TTM)
—
Div Yield
—
ROE
-173.5%
Debt/Equity
—
52W Range
$1 – $13
MTVA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
$-7.35
2020-12-31
→
2025-12-31
Free Cash Flow
$-16M
2019-12-31
→
2025-12-31
Margins
-2543.7%
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
MTVA
Peer Median
P/E (TTM)
-0.2
—
P/S (TTM)
6.7
21.9
P/B
0.6
1.3
Price / FCF
-0.2
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
MTVA
Peer Median
Operating Margin
-2687.8%
—
Net Profit Margin
-2543.7%
-2916.8%
ROA
-94.8%
-82.1%
ROE
-173.5%
-92.1%
ROIC
-257.0%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
MTVA
Peer Median
Current Ratio
1.9
2.6
Quick Ratio
1.8
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
MTVA
Peer Median
Revenue YoY
-44.6%
—
Revenue CAGR 3Y
303.5%
—
Revenue CAGR 5Y
67.2%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
MTVA
Peer Median
MTVA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
8 analysts
- Strong Buy 2 25.0%
- Buy 5 62.5%
- Hold 1 12.5%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
3 analysts · 2026-08-15
Median
$20.00
← Below all targets
$1.49
Low
$8.00
High
$30.00
Median target
$20.00
+1242.3%
Mean target
$19.33
+1197.5%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
1.0%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.90 | $-0.84 | -0.06% |
| March 31, 2026 | $-0.79 | $-0.76 | -0.03% |
| Dec. 31, 2025 | $-0.42 | $-1.27 | 0.85% |
| Sept. 30, 2025 | $-1.54 | $-2.49 | 0.95% |
| June 30, 2025 | $-2.86 | $-3.48 | 0.62% |
| March 31, 2025 | $-3.96 | $-6.76 | 2.8% |
| Dec. 31, 2024 | $-5.54 | $-7.60 | 2.1% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| MTVA | $19M | -1.1 | -44.6% | -2543.7% | -173.5% | — |
| LSTA | — | -1.0 | -83.0% | — | — | — |
| BIVI | — | — | — | — | — | — |
| LNAI | $513M | -2.7 | — | — | -586.4% | — |
| XCUR | $35M | -6.9 | — | — | -77.3% | — |
| VTGN | — | -0.3 | 161.1% | -5491.3% | -136.8% | — |
| IMNN | $13M | -0.6 | — | — | -298.2% | — |
| LIMN | — | — | — | — | — | — |
| SNGX | $14M | -0.6 | -85.8% | — | -311.2% | — |
| APRE | $7M | -0.4 | — | — | -97.5% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 13
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $7M | $22M | · | · | · | · | · | · | · | · | · | |
| SG&A Expense | $7M | $7M | $7M | $9M | $9M | $8M | $3M | $2M | $10M | $6M | $3M | |
| Operating Expenses | $14M | $29M | $16M | $20M | $15M | $30M | $20M | $15M | $33M | $15M | $8M | |
| Operating Income | $-14M | $-29M | $-16M | $-20M | $-15M | $-30M | $-20M | $-15M | $-33M | $-15M | $-8M | |
| Other Non-op | $735.0K | $1M | $3M | $6M | $14.0K | $-1.0K | · | $-3.0K | $-5.0K | $-4.0K | $7.0K | |
| Pretax Income | $-13M | $-28M | $-12M | $-14M | $-15M | $-30M | $-21M | $-16M | $-33M | $-15M | $-9M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-13M | $-28M | $-12M | $-14M | $-15M | $-30M | $-21M | $-16M | $-33M | $-15M | $-9M | |
| EPS (Basic) | $-7.35 | $-39.13 | $-2.46 | $-43.42 | $-19.81 | $-1.83 | · | · | · | · | · | |
| EPS (Diluted) | $-7.35 | $-39.13 | $-2.46 | $-43.42 | $-19.81 | $-1.83 | · | · | · | · | · | |
| Shares (Basic) | 1,766,026 | 705,193 | 5,071,101 | 321,703 | 771,422 | 16,217,339 | · | · | · | · | · | |
| Shares (Diluted) | 1,766,026 | 705,193 | 5,071,101 | 321,703 | 771,422 | 16,217,339 | · | · | · | · | · | |
| EBITDA | $-14M | $-29M | $-16M | $-20M | $-15M | · | $-20M | $-23M | · | $-15M | · |
Balance Sheet 22
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $16M | $22M | $33M | $16M | $10M | $14M | $3M | $18M | $24M | $4M | |
| Prepaid Expense | $597.0K | $55.0K | $77.0K | $168.0K | $197.0K | $546.0K | $153.0K | $929.0K | $490.0K | $713.0K | $23.0K | |
| Other Current Assets | · | · | $64.0K | $168.0K | · | $48.0K | $42.0K | $34.0K | $25.0K | · | · | |
| Current Assets | $11M | $16M | $23M | $34M | $17M | $11M | $14M | $4M | $19M | $25M | $4M | |
| PP&E (Net) | $17.0K | $34.0K | $46.0K | $2.0K | $110.0K | $155.0K | $200.0K | $3.0K | · | · | · | |
| PP&E (Gross) | $90.0K | $88.0K | $80.0K | $30.0K | $221.0K | $218.0K | $217.0K | $3.0K | · | · | · | |
| Accum. Depreciation | $73.0K | $54.0K | $34.0K | $28.0K | $111.0K | $63.0K | $17.0K | · | · | · | · | |
| Other Non-current Assets | $21.0K | $21.0K | $21.0K | · | · | $155.0K | $34.0K | · | · | $8.0K | · | |
| Total Assets | $11M | $16M | $23M | $34M | $17M | $11M | $14M | $4M | $19M | $25M | $4M | |
| Accounts Payable | $1M | $4M | $821.0K | $708.0K | $830.0K | $3M | $638.0K | $170.0K | $4M | $2M | $531.0K | |
| Accrued Liabilities | · | · | $4M | $280.0K | $1M | $1M | $1M | $49.0K | $1M | $2M | $2M | |
| Current Liabilities | $6M | $8M | $6M | $12M | $2M | $4M | $2M | $219.0K | $6M | $4M | $9M | |
| Capital Leases | $142.0K | $58.0K | $136.0K | · | $45.0K | $70.0K | $94.0K | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $1.0K | $3.0K | $1.0K | · | |
| Total Liabilities | $6M | $8M | $6M | $12M | $2M | $4M | $2M | $360.0K | $15M | $4M | $9M | |
| Common Stock | $2.0K | $1.0K | $5.0K | $25.0K | $1.0K | $20.0K | $16.0K | $22.0K | $18.0K | $17.0K | $12.0K | |
| Paid-in Capital | $154M | $144M | $125M | $118M | $96M | $74M | $49M | $2M | $64M | $48M | · | |
| Retained Earnings | $-149M | $-136M | $-108M | $-96M | $-82M | $-67M | $-37M | $-16M | $-60M | $-27M | $-12M | |
| AOCI | · | · | · | · | $4.0K | $14.0K | $12.0K | $2.0K | · | · | · | |
| Stockholders' Equity | $5M | $8M | $17M | $22M | $15M | $7M | $12M | $-13M | $25.0K | $21M | $-12M | |
| Liabilities + Equity | $11M | $16M | $23M | $34M | $17M | $11M | $14M | $4M | $19M | $25M | $4M | |
| Shares Outstanding | 2,308,294 | 785,194 | 4,906,000 | 3,179,502 | 888,693 | 19,671,182 | 15,592,718 | 5,166,812 | 10,633,042 | 9,270,255 | 3,758,488 |
Cash Flow 11
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $411.0K | $538.0K | $222.0K | $854.0K | $662.0K | $699.0K | $118.0K | $4M | $5M | $2M | $284.0K | |
| Deferred Tax | $-2M | $-8M | $-3M | $26M | $-4M | $-13M | $-7M | $-4M | · | · | · | |
| Operating Cash Flow | $-16M | $-25M | $-11M | $-12M | $-15M | $-11M | $-7M | $-14M | $-27M | $-11M | $-5M | |
| CapEx | $2.0K | $8.0K | $50.0K | · | $3.0K | $4.0K | $214.0K | $3.0K | · | · | · | |
| Investing Cash Flow | $-2.0K | $-8.0K | $-50.0K | $8.0K | $-586.0K | $69.0K | $-6M | $-3.0K | · | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | $10M | $3M | $6M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $3.0K | |
| Financing Cash Flow | $10M | $18M | $-80.0K | $29M | $22M | $7M | $24M | $17M | $21M | $31M | $9M | |
| Net Change in Cash | · | · | · | · | · | · | · | $481.0K | $-6M | $20M | $3M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-16M | $-25M | $-11M | · | $-15M | · | $-7M | · | · | · | · |
Profitability 7
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2687.8% | -3131.4% | -3446.0% | · | -109271.4% | · | 91709.1% | 3487.0% | · | -12891.2% | · | |
| Net Margin | -2543.7% | -2999.1% | -2705.0% | · | -109171.4% | · | 96872.7% | 3614.2% | · | -12794.7% | · | |
| Pretax Margin | -2543.7% | -2999.1% | -2705.0% | · | -109171.4% | · | 96872.7% | 3614.2% | · | -12794.7% | · | |
| EBITDA Margin | -2687.8% | -3131.4% | -3446.0% | · | -109271.4% | · | 91709.1% | 3487.0% | · | -12891.2% | · | |
| ROA | -94.8% | -141.3% | -44.3% | -55.5% | -110.1% | · | -233.1% | -122.1% | · | -99.8% | · | |
| ROE | -173.5% | -264.2% | -65.2% | -100.9% | -147.5% | · | 485.0% | -253.8% | · | -61.3% | · | |
| ROIC | -257.0% | -363.2% | -95.2% | -90.2% | -104.8% | · | -164.1% | -293.4% | · | -71.2% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.9 | 3.8 | 2.8 | 7.7 | · | 6.8 | 1.7 | · | 6.0 | · | |
| Quick Ratio | 1.8 | 1.9 | 3.8 | 2.8 | 7.6 | · | 6.7 | 1.6 | · | 5.8 | · |
Efficiency 1
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | 0.0 | · | -0.0 | -0.0 | · | 0.0 | · |
Growth Rates 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -44.6% | 99.6% | · | · | -64.1% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | 303.5% | 127.8% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 67.2% | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $510.0K | $920.0K | $461.0K | $20.0K | $14.0K | $39.0K | $-22.0K | $-40.0K | $-286.0K | $114.0K | · | |
| Net Income TTM | $-13M | $-28M | $-12M | $-14M | $-15M | $-30M | $-21M | $-16M | $-33M | $-15M | · | |
| Market Cap | $19M | $18M | $18M | $5M | $7.81B | · | $32.74B | $69.33B | · | $436.07B | · | |
| P/E | -1.1 | -0.1 | -1.5 | -0.1 | -14.8 | -688.5 | · | · | · | · | · | |
| P/S | 38.1 | 19.1 | 39.3 | 255.2 | 557611.9 | · | -1488395.8 | -1733247.4 | · | 3825200.0 | · | |
| P/B | 3.6 | 2.2 | 1.1 | 0.2 | 534.8 | · | 2663.9 | 8918.2 | · | 21135.8 | · | |
| P / Tangible Book | 3.6 | 2.2 | 1.1 | 0.2 | 534.8 | 3441.0 | · | · | · | · | · | |
| P / Cash Flow | -1.2 | -0.7 | -1.7 | -0.4 | -515.8 | · | -4651.9 | -3164.2 | · | -39488.6 | · | |
| P / FCF | -1.2 | -0.7 | -1.7 | · | -515.7 | · | -4514.6 | · | · | · | · | |
| Earnings Yield | -87.3% | -1927.6% | -66.5% | -755.9% | -6.8% | -0.15% | · | · | · | · | · |
Income Statement 13
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $2M | $241.0K | $2M | $2M | $2M | $4M | $5M | $8M | · | · | · | · | · | · | · | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $3M | |
| Operating Expenses | $5M | $4M | $2M | $3M | $4M | $4M | $6M | $6M | $10M | $7M | $6M | $4M | $4M | $3M | $10M | $3M | |
| Operating Income | $-5M | $-4M | $-2M | $-3M | $-4M | $-4M | $-6M | $-6M | $-10M | $-7M | $-6M | $-4M | $-4M | $-3M | $-10M | $-3M | |
| Other Non-op | $69.0K | $202.0K | $116.0K | $98.0K | $306.0K | $215.0K | $412.0K | $607.0K | $31.0K | $167.0K | $353.0K | $75.0K | $3M | $-84.0K | · | · | |
| Pretax Income | $-5M | $-4M | $-2M | $-3M | $-4M | $-4M | $-5M | $-6M | $-10M | $-7M | $-5M | $-4M | $-734.0K | $-3M | $-5M | $-3M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-5M | $-4M | $-2M | $-3M | $-4M | $-4M | $-5M | $-6M | $-10M | $-7M | $-5M | $-4M | $-734.0K | $-3M | $-5M | $-3M | |
| EPS (Basic) | $-0.90 | $-0.79 | $-6.59 | $-0.14 | $-2.87 | $-3.93 | $-35.41 | $-0.55 | $-1.85 | $-1.32 | $-1.05 | $-0.75 | $-0.15 | $-0.51 | $-32.96 | $-3.50 | |
| EPS (Diluted) | $-0.90 | $-0.79 | $-6.59 | $-0.14 | $-2.87 | $-3.93 | $-35.41 | $-0.55 | $-1.85 | $-1.32 | $-1.05 | $-0.75 | $-0.15 | $-0.51 | $-32.96 | $-3.50 | |
| Shares (Basic) | 5,931,875 | 4,859,567 | -48,201,330 | 24,415,876 | 1,389,753 | 933,109 | -20,027,208 | 10,214,087 | 5,428,906 | 5,089,408 | -10,122,722 | 5,075,817 | 5,059,003 | 5,059,003 | -2,344,376 | 888,693 | |
| Shares (Diluted) | 5,931,875 | 4,859,567 | -48,201,330 | 24,415,876 | 1,389,753 | 933,109 | -20,027,208 | 10,214,087 | 5,428,906 | 5,089,408 | -10,122,722 | 5,075,817 | 5,059,003 | 5,059,003 | -2,344,376 | 888,693 | |
| EBITDA | $-5M | $-4M | · | $-3M | $-4M | $-4M | · | $-6M | $-10M | $-7M | · | $-4M | $-4M | $-3M | · | $-3M |
Balance Sheet 20
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $14M | $10M | $14M | $18M | $11M | $16M | $22M | $28M | $16M | $22M | $26M | $29M | $31M | $33M | $6M | |
| Prepaid Expense | $433.0K | $431.0K | $597.0K | $369.0K | $726.0K | $771.0K | $55.0K | $266.0K | $583.0K | $776.0K | $77.0K | $308.0K | $486.0K | $670.0K | $168.0K | $859.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | $508.0K | · | · | · | · | $168.0K | · | |
| Current Assets | $13M | $14M | $11M | $15M | $18M | $12M | $16M | $22M | $29M | $17M | $23M | $26M | $29M | $31M | $34M | $8M | |
| PP&E (Net) | $8.0K | $12.0K | $17.0K | $22.0K | $27.0K | $30.0K | $34.0K | $39.0K | $44.0K | $47.0K | $46.0K | $41.0K | $5.0K | $5.0K | $2.0K | $3.0K | |
| PP&E (Gross) | $90.0K | $90.0K | $90.0K | $90.0K | $90.0K | $88.0K | $88.0K | $88.0K | $88.0K | $85.0K | $80.0K | · | · | · | $30.0K | $30.0K | |
| Accum. Depreciation | $82.0K | $78.0K | $73.0K | $68.0K | $63.0K | $58.0K | $54.0K | $49.0K | $44.0K | $38.0K | $34.0K | $30.0K | $29.0K | $29.0K | $28.0K | $27.0K | |
| Other Non-current Assets | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | · | · | · | · | |
| Total Assets | $13M | $14M | $11M | $15M | $18M | $12M | $16M | $22M | $29M | $17M | $23M | $26M | $29M | $31M | $34M | $8M | |
| Accounts Payable | $921.0K | $1M | $1M | $3M | $3M | $3M | $4M | $1M | $3M | $2M | $821.0K | $2M | $967.0K | $1M | $708.0K | $1M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | $4M | · | $2M | $2M | $417.0K | $280.0K | $544.0K | |
| Current Liabilities | $6M | $5M | $6M | $8M | $9M | $8M | $8M | $9M | $10M | $7M | $6M | $5M | $4M | $11M | $12M | $2M | |
| Capital Leases | $103.0K | $123.0K | $142.0K | · | $15.0K | $37.0K | $58.0K | $79.0K | $98.0K | $117.0K | $136.0K | $153.0K | · | · | · | · | |
| Total Liabilities | $6M | $5M | $6M | $8M | $9M | $8M | $8M | $9M | $10M | $7M | $6M | $5M | $4M | $11M | $12M | $2M | |
| Common Stock | $7.0K | $5.0K | $2.0K | $24.0K | $24.0K | $9.0K | $1.0K | $9.0K | $8.0K | $5.0K | $5.0K | $38.0K | $38.0K | $27.0K | $25.0K | $1.0K | |
| Paid-in Capital | $165M | $162M | $154M | $153M | $153M | $144M | $144M | $144M | $144M | $125M | $125M | $124M | $124M | $119M | $118M | $97M | |
| Retained Earnings | $-158M | $-153M | $-149M | $-147M | $-144M | $-140M | $-136M | $-131M | $-125M | $-115M | $-108M | $-103M | $-99M | $-98M | $-96M | $-91M | |
| Stockholders' Equity | $7M | $9M | $5M | $6M | $10M | $4M | $8M | $13M | $19M | $10M | $17M | $22M | $25M | $21M | $22M | $6M | |
| Liabilities + Equity | $13M | $14M | $11M | $15M | $18M | $12M | $16M | $22M | $29M | $17M | $23M | $26M | $29M | $31M | $34M | $8M | |
| Shares Outstanding | 6,575,656 | 5,164,370 | 2,308,294 | 24,215,000 | 24,194,000 | 8,655,000 | 785,194 | 8,609,000 | 8,221,000 | 4,906,000 | 4,906,000 | 38,429,185 | 38,241,685 | 27,176,685 | 3,179,502 | 888,693 |
Cash Flow 6
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $130.0K | $100.0K | $71.0K | $97.0K | $111.0K | $132.0K | $160.0K | $139.0K | $134.0K | $105.0K | $100.0K | $172.0K | $24.0K | $-74.0K | $218.0K | $218.0K | |
| Operating Cash Flow | $-4M | $-4M | $-5M | $-3M | $-3M | $-5M | $-5M | $-6M | $-7M | $-6M | $-3M | $-3M | $-2M | $-3M | $-2M | $-2M | |
| CapEx | · | · | $0 | $0 | · | · | $0 | $0 | $3.0K | $5.0K | $9.0K | $37.0K | $0 | $4.0K | · | · | |
| Investing Cash Flow | · | · | $0 | $0 | · | · | $0 | $0 | $-3.0K | $-5.0K | $-9.0K | $-37.0K | $0 | $-4.0K | $0 | $0 | |
| Financing Cash Flow | $3M | $8M | $861.0K | $-357.0K | $9M | $-12.0K | $-183.0K | $-717.0K | · | · | $0 | $0 | · | · | $29M | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-6M | · | · | · | $-3M | · | · |
Profitability 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -7376.7% | -4735.3% | · | -2301.3% | -2945.9% | -3035.9% | · | -2019.0% | -6148.8% | -2903.4% | · | -2403.1% | · | · | · | · | |
| Net Margin | -7282.2% | -4497.7% | · | -2236.4% | -2736.3% | -2868.0% | · | -1823.2% | -6129.9% | -2832.9% | · | -2356.8% | · | · | · | · | |
| Pretax Margin | -7282.2% | -4497.7% | · | -2236.4% | -2736.3% | -2868.0% | · | -1823.2% | -6129.9% | -2832.9% | · | -2356.8% | · | · | · | · | |
| EBITDA Margin | -7376.7% | -4735.3% | · | -2301.3% | -2945.9% | -3035.9% | · | -2019.0% | -6148.8% | -2903.4% | · | -2403.1% | · | · | · | · | |
| ROA | -33.5% | -28.8% | · | -18.3% | -16.9% | -25.2% | · | -23.3% | -34.7% | -27.7% | · | -22.5% | -3.7% | -11.6% | · | -39.8% | |
| ROE | -64.6% | -56.8% | · | -35.0% | -28.0% | -50.8% | · | -32.8% | -45.6% | -43.9% | · | -27.8% | -4.3% | -16.1% | · | -51.6% | |
| ROIC | -78.9% | -44.4% | · | -54.9% | -44.7% | -88.7% | · | -48.3% | -53.2% | -68.3% | · | -18.1% | -15.1% | -12.3% | · | -52.3% |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 2.7 | · | 1.7 | 2.1 | 1.6 | · | 2.4 | 2.9 | 2.5 | · | 5.5 | 7.3 | 2.9 | · | 4.7 | |
| Quick Ratio | 2.0 | 2.6 | · | 1.7 | 2.0 | 1.5 | · | 2.4 | 2.9 | 2.3 | · | 5.5 | 7.2 | 2.8 | · | 3.9 |
Efficiency 1
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | · | · |
Valuation (TTM) 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $455.0K | $510.0K | · | $735.0K | $748.0K | $839.0K | · | $873.0K | · | · | · | · | $20.0K | $20.0K | · | $20.0K | |
| Net Income TTM | $-17M | $-15M | · | $-17M | $-23M | $-26M | · | $-26M | $-21M | $-14M | · | $-10M | $-10M | $-12M | · | $-13M | |
| Market Cap | $9M | $6M | · | $23M | $16M | $13M | · | $27M | $40M | $20M | · | $146M | $134M | $154M | · | $97M | |
| P/E | -0.3 | -0.2 | · | -0.7 | -0.2 | -0.4 | · | -0.7 | -1.2 | -1.5 | · | -0.8 | -0.4 | -0.5 | · | -7.2 | |
| P/S | 20.7 | 12.2 | · | 31.0 | 20.8 | 15.9 | · | 31.3 | · | · | · | · | 6684.6 | 7718.2 | · | 4866.5 | |
| P/B | 1.4 | 0.7 | · | 3.6 | 1.6 | 3.0 | · | 2.1 | 2.1 | 2.0 | · | 6.8 | 5.3 | 7.5 | · | 16.4 | |
| P / Tangible Book | 1.4 | 0.7 | · | 3.6 | 1.6 | 3.0 | · | 2.1 | 2.1 | 2.0 | · | 6.8 | 5.3 | 7.5 | · | 16.4 | |
| P / Cash Flow | · | -1.5 | · | · | · | -2.8 | · | · | · | -3.1 | · | · | · | -60.6 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -3.1 | · | · | · | -60.5 | · | · | |
| Earnings Yield | -328.7% | -426.7% | · | -139.4% | -469.7% | -264.9% | · | -141.0% | -84.1% | -66.8% | · | -128.9% | -225.4% | -193.1% | · | -13.8% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Operating Margin % | -2687.8% | -3131.4% | -3446.0% | — | -109271.4% |
| Net Income | $-13M | $-28M | $-12M | $-14M | $-15M |
| Diluted EPS | $-7.35 | $-39.13 | $-2.46 | $-43.42 | $-19.81 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.9 | 3.8 | 2.8 | 7.7 |
| Quick Ratio | 1.8 | 1.9 | 3.8 | 2.8 | 7.6 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $-16M | $-25M | $-11M | — | $-15M |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 18 filers · $384K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 7 (+3 vs prior Q) | 0 (-4 vs prior Q) | 2 (0 vs prior Q) | 3 (+2 vs prior Q) | +193K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| JANE STREET GROUP, LLC | $137,331 | 96,036 | 35.75% | Shares |
| CITADEL ADVISORS LLC | $87,525 | 61,206 | 22.78% | Shares |
| VANGUARD GROUP INC | $71,789 | 8,526 | 18.69% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $29,716 | 20,781 | 7.74% | Shares |
| Scientech Research LLC | $17,180 | 12,014 | 4.47% | Shares |
| Aries Wealth Management | $14,300 | 10,000 | 3.72% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $12,754 | 8,919 | 3.32% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $9,924 | 6,940 | 2.58% | Shares |
| Tower Research Capital LLC (TRC) | $3,179 | 2,223 | 0.83% | Shares |
| SBI Securities Co., Ltd. | $386 | 270 | 0.10% | Shares |
| Virtu Financial LLC | $43 | 29,933 | 0.01% | Shares |
| MORGAN STANLEY | $14 | 10 | 0.00% | Shares |
| BlackRock, Inc. | $10 | 7 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $4 | 3 | 0.00% | Shares |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $3 | 2 | 0.00% | Shares |
| BROWN BROTHERS HARRIMAN & CO | $3 | 2 | 0.00% | Shares |
| DANSKE BANK A/S | $3 | 2 | 0.00% | Shares |
| UBS Group AG | $1 | 1 | 0.00% | Shares |
Company insiders 24 insiders · 9 officers · 17 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Hyung Heon Kim | CEO & President | Jan. 23, 2026 A | 37,545 | 0 | 0 | $0 |
| Sooch Mina | President & CEO | Aug. 10, 2016 C | 693,732 | 0 | 0 | $0 |
| Marshall H Woodworth | Chief Financial Officer | Jan. 23, 2026 A | 30,734 | 0 | 0 | $0 |
| Jeffrey S Mathiesen | Chief Financial Officer | Aug. 10, 2017 M | 10,927 | 0 | 0 | $0 |
| Akash Bakshi | SVP and COO | Dec. 31, 2020 A | 884,072 | 0 | 0 | $0 |
| David Lowenschuss | Chief Legal Off. & Secretary | Aug. 10, 2016 P | 806,247 | 0 | 0 | $0 |
| Seth Reno | Chief Commercial Officer | Aug. 10, 2016 P | 4,000 | 0 | 0 | $0 |
| Carmen Daniela Oniciu | Vice President | Aug. 10, 2016 C | 152,401 | 0 | 0 | $0 |
| Charles Bisgaier PhD | Chair & Chief Scientific Off. | Aug. 10, 2016 C | 1,244,440 | 0 | 0 | $0 |
| Michael Salsbury | Director | June 8, 2026 A | 21,338 | 0 | 0 | $0 |
| James Patrick Tursi | Director | June 8, 2026 A | 20,568 | 0 | 0 | $0 |
| Jason L Groves | Director | June 8, 2026 A | 21,338 | 0 | 0 | $0 |
| Mark A Glickman | Director | June 8, 2026 A | 20,629 | 0 | 0 | $0 |
| Andrew I Koven | Director | June 8, 2026 A | 21,339 | 0 | 0 | $0 |
| Gordon D Strickland | Director | June 8, 2026 A | 21,339 | 0 | 0 | $0 |
| Kim Na Yeon | Director | July 27, 2023 A | 101,459 | 0 | 0 | $0 |
| Richard Kang | Director | June 9, 2022 A | — | 0 | 0 | $0 |
| Douglas J Swirsky | Director | Sept. 1, 2020 A | — | 0 | 0 | $0 |
| Kent P. Hawryluk | Director | Aug. 10, 2016 C | 56,889 | 0 | 0 | $0 |
| Steven R. Gullans Ph.D. | Director | Aug. 10, 2016 C | 806,025 | 0 | 0 | $0 |
| Andy Sassine | Director | Aug. 10, 2016 C | 115,145 | 0 | 0 | $0 |
| Pedro Lichtinger | Director | Aug. 10, 2016 C | 49,274 | 0 | 0 | $0 |
| DONG-A ST CO., LTD | 10% owner | May 8, 2025 P | 9,995,679 | 0 | 0 | $0 |
| Kenneth W Kousky | — | Aug. 10, 2016 C | 1,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 7 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Dong-A ST Co., Ltd., Dong-A Socio Holdings Co., Ltd. | May 20, 2025 | 51.10% | Amendment | — | SEC |
| (S.S. or ×8 filings | Sept. 20, 2024 | — | Initial filing | — | SEC |
| JK BioPharma Solutions, Inc., Sun Dae Kang ×3 filings | Sept. 23, 2022 | — | Initial filing | — | SEC |
| The E&Healthcare Investment Fund II, The E&Healthcare Investment Fund No. 6, The E&Healthcare Investment Fund No. 7, E&Investment, Inc., Na Yeon Kim ×4 filings | Aug. 5, 2022 | — | Initial filing | — | SEC |
| NeuroBo Therapeutics, Inc. (f/k/a/ NeuroBo Pharmaceuticals, Inc.) | Jan. 16, 2020 | — | Initial filing | — | SEC |
| Charles L. Bisgaier ×2 filings | Jan. 10, 2020 | — | Initial filing | M&A / sale | SEC |
| NeuroBo Pharmaceuticals, Inc. | Aug. 2, 2019 | — | Initial filing | M&A / sale | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 8,919 SH | Aug. 8, 2026 | Daily |